Gastroenterological and psychological characteristics of patients seeking bariatric surgery

2021 ◽  
pp. 5-10
Author(s):  
D. I. Vasilevsky ◽  
S. G. Balandov ◽  
K. A. Anisimova ◽  
S. V. Tikhonov ◽  
V. D. Dekkanova ◽  
...  

This original article discusses the main concomitant diseases and psychological problems of patients with morbid obesity seeking help from bariatric (metabolic) surgeons. The study was conducted on the basis of St. Petersburg State Medical University n. a. I. P. Pavlov, it was the most voluminous laboratory-instrumental and psychological examination, on the basis of which a peculiar portrait of a Russian patient with morbid obesity was compiled. Gastroenterological symptoms were predominant in patients with morbid obesity. Heartburn was the most common complaint. Non-erosive reflux disease was diagnosed in 35.0 % of patients, erosive esophagitis in 20.5 %, hiatal hernia of the 1st degree in 41.2 %, of the 2nd degree in 32.3 % of patients.

2013 ◽  
Vol 23 (11) ◽  
pp. 1939-1941 ◽  
Author(s):  
Alberto Zalar ◽  
Baya Haddouche ◽  
Michel Antonietti ◽  
Raied Alhameedi ◽  
Isabelle Iwanicki-Caron ◽  
...  

2021 ◽  
pp. 44-52
Author(s):  
S. V. Tikhonov ◽  
K. A. Anisimova ◽  
V. D. Dekkanova ◽  
K. V. Papin ◽  
N. V. Rodionova ◽  
...  

Obesity is the 21st century pandemic. By 2025 6 % of men and 9 % of women will suffer from morbid obesity. For morbid obesity bariatric surgery is the main treatment option. The presence of pathology of the upper gastrointestinal tract (GERD) determines the choice of surgical intervention. The study involved 68 patients 47.1 ± 10.2 years with morbid obesity. Patients had the following gastroenterological pathologies: erosive esophagitis – 6 (8.8 %), hiatal hernia – 9 (13 %), erosive and ulcerative lesions of the stomach and duodenum – 13 (19 %). Heartburn disturbed 38 (55 %), regurgitation – 17 (25 %), severity and feeling of fullness in the epigastrium – 29 (42 %), pain or burning in the epigastrium – 8 (11 %) patients. Fifty (73.5 %) patients underwent laparoscopic sleeve gastrectomy, 18 (26.5 %) patients – laparoscopic Roux-en-Y gastric bypass. Comprehensive preoperative examination (x-ray of the upper gastrointestinal tract with barium, daily pH impedance measurement, esophageal manometry) and phenotyping of GERD lead to reduction of GERD symptoms in patients with morbid obesity after sleeve gastrectomy.


2003 ◽  
Vol 124 (4) ◽  
pp. A541
Author(s):  
Mohamed Merrouche ◽  
Simon Msika ◽  
Florence Harnois ◽  
Jean Marc Sabate ◽  
Benoit Coffin

2020 ◽  
Vol 11 (4) ◽  
pp. 134-139
Author(s):  
Robin Mauricio Yance Hurtado ◽  
Thiago Ferreira de Souza ◽  
Manoel dos Passos Galvão Neto ◽  
Eduardo Grecco ◽  
Sergio A Barrichello Junior ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Hidetaka Ichikawa ◽  
Hirofumi Imoto ◽  
Naoki Tanaka ◽  
Hiroaki Musha ◽  
Shojiro Sawada ◽  
...  

Abstract Background Bariatric surgery is effective for the treatment of patients with morbid obesity and type 2 diabetes mellitus (T2DM), for body weight loss and glycemic control. However, in Japan, there has been no previous report of the effectiveness bariatric surgery in a case of morbid obesity associated with acute onset type 1 diabetes mellitus (T1DM), in which pancreatic β-cells were destroyed and endogenous insulin was depleted. Case presentation A 36-year-old woman with morbid obesity and T1DM, diagnosed when she was 6 years, was admitted for bariatric surgery. At her first consultation, she had a body weight of 106.7 kg and a body mass index of 42.2 kg/m2. Her HbA1c level was 9.0%, with a required daily insulin dose of 75 units. She underwent laparoscopic sleeve gastrectomy. At 1 year after surgery, her body weight had decreased to 81.0 kg and her body mass index to 32.2 kg/m2. In addition, her daily required dose of insulin had decreased to 24 units, with an improvement in her HbA1c level to 7.7%. Conclusions Although further evidence needs to be accumulated, including long-term outcomes, laparoscopic sleeve gastrectomy may provide an effective treatment for patients with morbid obesity and T1DM for body weight loss, improvement in HbA1c level, and insulin dose reduction.


Sign in / Sign up

Export Citation Format

Share Document